02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
01.06.2012
- AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif Johansson's first priority is to find a permanent...
01.06.2012
- Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...
28.05.2012
- Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...
26.04.2012
- Financier Carl Icahn said he has voluntarily dismissed a lawsuit filed against Amylin Pharmaceuticals after talking with the biotech company's chief executive, Daniel Bradbury...
09.04.2012
- Carl Icahn sued Amylin Pharmaceuticals on Monday to extend a deadline for nominating directors, as the activist investor pushes to win enough board seats to engineer a sale of the...
